Registrational Study for 150 Mg/m2 Dose
Phase of Trial: Phase II
Latest Information Update: 20 Sep 2007
At a glance
- Drugs Lamivudine; Nevirapine; Zidovudine
- Indications HIV infections
- Focus Pharmacokinetics; Therapeutic Use
- Sponsors Boehringer Ingelheim
- 31 Aug 2018 Biomarkers information updated
- 20 Sep 2007 The expected completion date for this trial is now 1 Dec 2004.
- 30 Aug 2007 Status change from in progress to completed.